Biotherapeutics Analytical Instrumentation for AI, R&D and Manufacturing [ HT multi-attribute multi-variate (MAM) and label free analysis].
PDS’ ProteinMentor ™ is a breakthrough platform technology for biopharma allowing real-time monitoring of an array of proteins in solution during gentle perturbation to assess Critical Quality Attributes (CQAs) providing insights into formulation optimization, stability, charge variance, proteinaceous particle generation propensity, as well as detecting sample contamination by bacteria or other foreign organisms. ProteinMentor software platform uses Quantum Cascade Laser Infrared (QCL IR) microscopy -200x faster than existing FT-IR - for deep real-time proteins in solution analysis and an innovative slide cell array for evaluation of CQA’s across candidate selection, drug design and manufacturing product release-testing. ProteinMentor's capabilities are enabled by unprecedented HT multi-attribute multi-variate (MAM) and label free analysis of proteins in solution (drug product/drug substance) without formulation limitations.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 13, 2016 | Grant | $1.42M | 1 | National Science Foundation | — | Detail |
Dec 11, 2014 | Grant | $179.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |